Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Giant cell tumour of tendon sheath: experience with 52 cases

< Back to Listing

Share this Article

Singapore Med J 2008; 49(11): 879-882
Giant cell tumour of tendon sheath: experience with 52 cases

  • Abstract
  • PDF

Darwish FM, Haddad WH
Correspondence: Dr Fayeq M Darwish, fayeq_d@yahoo.com

ABSTRACT
Introduction
The aim of this retrospective study was to study the clinical presentation, investigations, histopathological findings, and the best ways of treatment of the giant cell tumour of the tendon sheath (GCTTS).
Methods The medical records of all patients diagnosed to have GCTTS during the period 1994-2001 were reviewed, and follow-up was for three to ten years.
Results The total number of patients was 52, of whom 36 were females, and the mean age was 32.4 years. All the tumours except one were located in the hand and wrist area, with the thumb being the most affected finger. Painless swelling was the most common presentation. All of them were treated surgically and the recurrence rate was 24 percent.
Conclusion After reviewing the literature and comparing with our results, we conclude that GCTTS is a true benign tumour with local aggressive behaviour in some cases, and the best way of treatment is wide local excision.

Keywords: giant cell tumour of the tendon sheath, hand tumours, nodular synovitis, pigmented nodular synovitis, synovial tumours, wrist tumours
Singapore Med J 2008; 49(11): 879-882

http://smj.org.sg/sites/default/files/4911/4911a4.pdf
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.